Histidine-Tryptophan-Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Deceased Donor Livers, Especially Those Donated After Cardiac Death

Title
Histidine-Tryptophan-Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Deceased Donor Livers, Especially Those Donated After Cardiac Death
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 9, Issue 2, Pages 286-293
Publisher
Wiley
Online
2008-12-05
DOI
10.1111/j.1600-6143.2008.02478.x

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started